Senior Clinical Fellow in Haematology Early Phase Clinical Trials

Job Advert Skip to main content Cookies on NHS Jobs We've put some small files called cookies on your device to help us make improvements to our site. To improve our site we'd also like to use cookies which will send information to Google Analytics. You can read more about our cookies before you choose. Accept analytics cookies Do not accept analytics cookies Jobs Menu Sign in Create an account English Cymraeg Menu Close menu Search Sign in Create an account Display in Welsh (Cymraeg) Search Sign in Create an account Display in Welsh (Cymraeg) BETA Your feedback will help us to improve this service. University College London Hospitals NHS Foundation Trust Senior Clinical Fellow in Haematology Early Phase Clinical Trials The closing date is 13 October 2026 Apply for this job Job summary Senior Clinical Fellow (ST6) in Haematology Early Phase Clinical Trials NIHR UCLH Clinical Research Facility Applications are invited for a Clinical Fellow (ST6) in Haematology Early Phase Clinical Trials from 1 February 2027. The aim of this position is to offer comprehensive specialist training in all aspects of running early phase haematology clinical trials including protocol development, regulatory procedures, associated translational research projects and presentation of research at meetings. Cancer is a major strategic area of UCLH and UCL with a focus on developing novel pathway-directed therapies. There is an excellent infrastructure allowing clinical trials to be linked with basic science, facilitating targeting of specific molecular abnormalities in cancers with therapeutics. UCL is both an Experimental Cancer Medicine Centre and a Cancer Research UK Centre, and the NIHR UCLH Clinical Research Facility (http://www.uclhospitals.brc.nihr.ac.uk/crf/national-institute-health-researchwellcome-uclh-clinical-research-facility) is supported by the NIHR and Cancer Research UK. There are close links between the CRF and the UCL Cancer Institute (http://www.ucl.ac.uk/cancer/) providing excellent opportunities for translational research projects linked to drug development. Main duties of the job This full-time, fixed-term post will be for a period of 12 months from 1 February 2027. Full GMC Registration is essential and possession of MRCP or equivalent is necessary. Specialist training in haematology or oncology and competency in prescribing chemotherapy is required, experience in clinical trial work is desirable. The aim of this position is to offer comprehensive specialist training in all aspects of early phase Haem-Oncology clinical trials including protocol development, regulatory procedures, associated translational research projects and presentation of research at meetings About us University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research. We provide first-class acute and specialist services across eight sites:o University College Hospital (incorporating the Elizabeth Garrett Anderson Wing)o National Hospital for Neurology and Neurosurgeryo Royal National ENT and Eastman Dental Hospitalso University College Hospital Grafton Way Buildingo Royal London Hospital for Integrated Medicineo University College Hospital Macmillan Cancer Centreo The Hospital for Tropical Diseaseso University College Hospital at Westmoreland Street We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women's health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology. We are committed to sustainability and have pledged to become a carbon net zero health service, embedd